FTC investigates contracts regarding autoimmune disease drug, Remicade
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
List view / Grid view
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
NICE has issued a recommendation for risankizumab to treat patients with severe plaque psoriasis.
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis...